Mutant p53 shapes the enhancer landscape of cancer cells in response to chronic immune signaling
Inflammation is known to affect cancer development, yet the mechanisms by which immune signaling drives transformation remain unclear. Here, the authors provide evidence that chronic TNF-α signaling promotes the enhancer binding and transcriptional interplay between mutant p53 and NFκB.
Guardado en:
Autores principales: | Homa Rahnamoun, Hanbin Lu, Sascha H. Duttke, Christopher Benner, Christopher K. Glass, Shannon M. Lauberth |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/afeca2176ca641f4a733a0cf6b0463bc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3
por: Catherine A. Vaughan, et al.
Publicado: (2021) -
Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation
por: Li Ren Kong, et al.
Publicado: (2020) -
Complexes formed by mutant p53 and their roles in breast cancer
por: Bellazzo A, et al.
Publicado: (2018) -
Diverse motif ensembles specify non-redundant DNA binding activities of AP-1 family members in macrophages
por: Gregory J. Fonseca, et al.
Publicado: (2019) -
Dysregulated phosphoinositide 3-kinase signaling in microglia: shaping chronic neuroinflammation
por: Erskine Chu, et al.
Publicado: (2021)